As we age, our bodies change and degenerate over time in a process called senescence. Stem cells, which have the unique ability to change into other cell types, also experience senescence, which presents an issue when trying to maintain cell cultures for therapeutic use.
Innate Pharma plans IND of ADC candidate after positive preclinical data – Pharmaceutical Technology
Share this article In preclinical studies, IPH45 effectively hinders the growth of tumours expressing Nectin-4, both in laboratory settings and in vivo. Credit: Gorodenkoff via